Synergistic inhibition of the growth of MDA‑MB‑231 cells in triple‑negative breast cancer by salinomycin combined with 17‑AAG and its mechanism-Reference-Cited by-同舟云学术

Synergistic inhibition of the growth of MDA‑MB‑231 cells in triple‑negative breast cancer by salinomycin combined with 17‑AAG and its mechanism

Published:2022-03-01 Issue:4 Volume:23 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

He Duo¹,Wu Bo¹,Du Juan¹,Li Ling²,Zhao Jumei¹

Affiliation:

1. Key Laboratory for Cancer Prevention and Treatment, Medical College of Yan'an University, Yan'an, Shaanxi 716000, P.R. China

2. National Translational Science Center for Molecular Medicine, Department of Cell Biology, School of Basic Medicine, The Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference46 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Triple-negative breast cancer: Who should receive neoadjuvant chemotherapy?;Chaudhary;Surg Oncol Clin N Am,2018

3. Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies;Lee;Cancer Treat Rev,2018

4. Metastatic and triple-negative breast cancer: Challenges and treatment options;Al-Mahmood;Drug Deliv Transl Res,2018

5. Classification, treatment strategy, and associated drug resistance in breast cancer;Tang;Clin Breast Cancer,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of X10g as a selective PROTAC degrader of Hsp90α protein for treating breast cancer;European Journal of Medicinal Chemistry;2023-11

2. Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles;Frontiers in Oncology;2023-05-05

3. Construct ceRNA Network and Risk Model of Breast Cancer Using Machine Learning Methods under the Mechanism of Cuproptosis;Diagnostics;2023-03-22